HEC ChangJiang Pharma IPO - Just a Manufacturing Shell
YiChang HEC ChangJiang Pharmaceuticals (YHCP) plans to raise US$160-215m through an issuance of primary shares in its IPO.We've worked along...
515 Views
𝛼SK or SearchENTITY
YiChang HEC ChangJiang Pharmaceutical (1558 HK)
YiChang HEC ChangJiang Pharmaceutical (1558 HK)
137
Analysis
Health Care • China
YiChang HEC ChangJiang Pharmaceutical develops, manufactures, and sells pharmaceutical products, focusing on anti-viral, endocrine and metabolic, and cardiovascular diseases. Key products include Kewei (oseltamivir phosphate), Oumeining (telmisartan), and Ertongshu (benzbromarone). The company was founded in 2001 and is headquartered in Dongguan, China.
morex